Peer Review reports
From: The effect of nafamostat mesilate infusion after ERCP for post-ERCP pancreatitis
| Original Submission | ||
|---|---|---|
| 28 May 2021 | Submitted | Original manuscript |
| 2 Nov 2021 | Reviewed | Reviewer Report |
| 26 Nov 2021 | Reviewed | Reviewer Report |
| 28 Feb 2022 | Reviewed | Reviewer Report - Jorge Canena |
| 16 Mar 2022 | Author responded | Author comments - Sang Hyub Lee |
| Resubmission - Version 2 | ||
| 16 Mar 2022 | Submitted | Manuscript version 2 |
| 22 Mar 2022 | Author responded | Author comments - Sang Hyub Lee |
| Resubmission - Version 3 | ||
| 22 Mar 2022 | Submitted | Manuscript version 3 |
| 8 Apr 2022 | Reviewed | Reviewer Report |
| 10 Apr 2022 | Reviewed | Reviewer Report - Jorge Canena |
| 24 Apr 2022 | Author responded | Author comments - Sang Hyub Lee |
| Resubmission - Version 4 | ||
| 24 Apr 2022 | Submitted | Manuscript version 4 |
| 28 Apr 2022 | Author responded | Author comments - Sang Hyub Lee |
| Resubmission - Version 5 | ||
| 28 Apr 2022 | Submitted | Manuscript version 5 |
| Publishing | ||
| 12 May 2022 | Editorially accepted | |
| 31 May 2022 | Article published | 10.1186/s12876-022-02345-3 |
You can find further information about peer review here.